TOPLINE: Women who have experienced infertility without fertility treatment show a 25% higher risk for systemic autoimmune rheumatic disease (SARD) up to 9 years after delivery compared with those without infertility. The association persists even after accounting for adverse pregnancy outcomes. METHODOLOGY: TAKEAWAY: IN PRACTICE: “Future research efforts should seek to corroborate this association by...
Tag: <span>rheumatic disease</span>
Post
Sinusitis linked to 40% heightened risk of rheumatic disease
by British Medical Journal Credit: Pixabay/CC0 Public DomainThe common inflammatory condition sinusitis is linked to a 40% heightened risk of a subsequent diagnosis of rheumatic disease, particularly in the five to 10 years preceding the start of symptoms, according to research published in the open access journal RMD Open. The risks seem to be greatest for...
Post
Different outcomes by race/ethnicity among patients with COVID-19 and rheumatic disease
WILEY Among U.S. patients with rheumatic disease and COVID-19, racial/ethnic minorities had higher risks of needing to be hospitalized and put on ventilators. The findings come from an analysis published in Arthritis & Rheumatology. The analysis included data on all U.S. patients with rheumatic disease and COVID-19 entered into the COVID-19 Global Rheumatology Alliance physician registry...
Post
Heart disease signs improve when using arthritis medication
Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research UNIVERSITY OF LEEDS Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research. Having rheumatoid arthritis (RA) is known to at least double...
Post
New study: Hydroxychloroquine ineffective as a preventive antiviral against COVID-19
CLEVELAND–Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for...
Post
Antibodies against phosphorylcholine give protection against rheumatic systemic disease
by Karolinska Institutet A novel study from the Institute of Environmental Medicine at Karolinska Institutet indicates that antibodies against a small lipid entity, phosphorylcholine (PC), can be associated with protection in inflammatory systemic diseases, including SLE and Sjögren’s syndrome. The results support evidence for a potential treatment by providing antibodies (anti-PC) to patients with these...
Post
Moving the diagosis of rheumatic diseases into the era of precision medicine
by Delthia Ricks , Medical Xpress Many rheumatic conditions develop slowly and initially have inflammatory arthritis as the first sign that something is amiss. The trouble with such close similarity is the difficulty that clinicians have differentiating one condition from another in the early stages of the disease process. Dr. Rachel Knevel and colleagues at...
Post
COVID-19 study good news for rheumatic disease patients on immunosuppressants
A European League Against Rheumatism (EULAR) database containing information on the effects of COVID-19 on patients with rheumatic and musculoskeletal diseases has given some reassurance to patients taking immunosuppressants. The drugs studied by the team include anti-malarial drugs, methotrexate, biological therapies such as TNF-alpha inhibitors, and nonsteroidal anti-inflammatory drugs such as Naproxen. None of them...
Post
EULAR: Hydroxychloroquine use in lupus patients ‘does not seem to prevent COVID-19’
by European League Against Rheumatism (EULAR) The current outbreak of COVID-19 represents a source of concern for the management of systemic lupus erythematous, SLE, patients. These patients have an increased risk of severe infections due to their underlying disease, the use of immunosuppressive drugs, as well as the potential presence of organ damage associated with...
Post
Coronary calcium score may ID CV risk in rheumatoid arthritis
(HealthDay)—The Coronary Calcium Score (CCS) may be a useful tool in cardiovascular (CV) risk assessment among female patients with rheumatoid arthritis (RA), according to a study published in the October issue of the International Journal of Rheumatic Diseases. Miguel Bernardes, M.D., from the University of Porto in Portugal, and colleagues assessed CCS (using computed tomography)...